New clinical trial
Relations of Glucose Variability With Cognitive Function and AD Risk Markers Among Older Adults at Risk for Diabetes
@gregoryai.bsky.social
@gregoryai.bsky.socialNew clinical trial
Relations of Glucose Variability With Cognitive Function and AD Risk Markers Among Older Adults at Risk for Diabetes
@gregoryai.bsky.socialNew clinical trial
A Prospective Multimodal Cohort Study of Cognitive Impairment and Progression From Mild Cognitive Impairment to Dementia
@gregoryai.bsky.socialNew clinical trial
Characteristics and Mechanism Research of Probable Alzheimer's Disease With Behavioral and Psychological Symptoms of Dementia With Negative Plasma p-tau217
@californiaalz.bsky.socialThank you @liccardo.house.gov for taking the time to meet with our #ENDALZ advocates today! We appreciate you considering joining the bipartisan effort and adding your name as a cosponsor of the #ASAPAct which will clear the way for blood biomarker screening tests for Alzheimer's.
@wbaltv11.bsky.socialMore than 1 in 10 people in Baltimore are touched by Alzheimer's disease, and together we can change that. Sign up for the Walk to End Alzheimer's at act.alz.org/baltimore. #Walk2EndAlz #ENDALZ
WBAL-TV 11 and 98 Rock are proud to be the official media partners.
@gregoryai.bsky.socialNew clinical trial
Co-Designing and Testing the Feasibility of a Gamified AI Medical Yoga App for Home-Based Cancer Rehabilitation
@alzassociation.bsky.socialIn the fight against Alzheimer’s, now matters more than ever. Now is the time for action. Start or join a #Walk2EndAlz team at alz.org/walk. #ENDALZ
@gregoryai.bsky.socialNew clinical trial
An Open-Label Extension and Safety Monitoring Study of Patients With Symptomatic Transthyretin Cardiomyopathy Who Have Completed the Phase II Study AG10-201
@gregoryai.bsky.socialNew clinical trial
A Multicenter, Phase 2, Open-Label, Randomized, Crossover Comparison of Two Formulations of Flutemetamol F 18 Injection
@gregoryai.bsky.socialNew clinical trial
Surgery and Postoperative Tau Pathology in Humans: A Translational Imaging and Biochemical Study to Explore Surgery-Induced Hallmarks of Alzheimer's Dementia
@gregoryai.bsky.socialNew clinical trial
Identificazione Del Profilo di microRNA Salivari Nella Malattia di Alzheimer e Sviluppo di un Nuovo Metodo di Rilevamento Basato su Biosensori
@gregoryai.bsky.socialNew clinical trial
Behavioral Shifts in Dementia Patients Using Novel Pharmacy Home Robotics: A Cost-Effective Approach to Aging in Place
@alzassociation.bsky.socialThe momentum is building. 💜 Over 70 Walk to End Alzheimer’s events brought communities together from coast to coast this weekend. Thank you to everyone who joined us! Over 215 Walks are still to come. Register today: alz.org/walk #ENDALZ
@alzassociation.bsky.socialFinal hours: Our Autumn 2X Match ends at midnight. Give now and your gift can go 2X as far for families facing Alzheimer's. bit.ly/47P3bTu #ENDALZ
@alzassociation.bsky.socialCaton Tsao grew up playing chess. Now he's using it to say checkmate to Alzheimer's. ♟️ He shares three reasons to participate in Do What You Love to End ALZ for #NationalChessDay. Make your move and start your fundraiser: alz.org/dowhatyoulove #DoWhatYouLove #ENDALZ
@alzassociation.bsky.socialCaton Tsao grew up playing chess. Now he's using it to say checkmate to Alzheimer's. ♟️ He shares three reasons to participate in Do What You Love to End ALZ for #NationalChessDay. Make your move and start your fundraiser: alz.org/dowhatyoulove #DoWhatYouLove #ENDALZ
@alzassociation.bsky.socialEnding soon: Only days left to make 2X the impact. Every gift to our Autumn 2X Match through Oct. 12 goes twice as far for research and care for families facing Alzheimer's. Give now: bit.ly/4y547hb #ENDALZ
@repbonamici.bsky.socialToday I participated in the 2026 Walk to End Alzheimer's at the @oregonzoo.bsky.social with @alzassociation.bsky.social
#EndAlz #WalkToEndAlzheimers
@gregoryai.bsky.socialNew clinical trial
A Randomized Controlled Trial of Peer Support for Family Caregivers of Black Older Adults Living With Dementia (Pair 2 Care)
@gregoryai.bsky.socialNew clinical trial
An Observational Registry Study to Evaluate the Use and Safety of LEQEMBI in Routine Clinical Practice in Taiwan